Lymph node metastases in endometrial carcinoma: A modern assessment in the era of sentinel lymph node mapping and molecular subtyping.
Praiss AM, Dagher C, Zhou Q, Iasonos A, Rios-Doria E, Abu-Rustum NR, Chiang S, Momeni-Boroujeni A, Weigelt B, Ellenson LH, Leitao MM Jr, Mueller JJ.
Praiss AM, et al.
Gynecol Oncol. 2024 Dec;191:37-44. doi: 10.1016/j.ygyno.2024.09.012. Epub 2024 Sep 26.
Gynecol Oncol. 2024.
PMID: 39332279
Free PMC article.
Three-year PFS rates by subtype for 68 patients with macro-metastases were 38 % (95 % CI 10-67 %) CN-low/no specific molecular subtype (CN-L/NSMP), 66 % (95 % CI 44-82 %) microsatellite instability-high (MSI-H), and 23 % (95 % CI 10-40 %) CN-H/TP53abn (p = 0.006). T …
Three-year PFS rates by subtype for 68 patients with macro-metastases were 38 % (95 % CI 10-67 %) CN-low/no specific molecular subtype (CN-L …